APPLIED STEMCELL

As a leading cell and gene therapy CRO/CDMO, Applied StemCell is a proud supporter of gene editing and stem cell therapy development. With two high-impact platforms, CRISPR/TARGATT™ Genome Editing and iPSC (GMP grade), we seek to help advance the development of novel therapeutics... Applied StemCell, a leading CRO/CDMO, specializes in iPSCs and genome editing. Our full spectrum services cover all cell-based project needs, from pre-clinical efficacy testing to cGMP-compliant cell manufacturing. Our iPSC services include iPSC generation, differentiation, and gene editing using CRISPR or our unique knock-in technology, TARGATT... Applied StemCell's technology and scientific experience has enabled a successful gene therapy pipeline for intractable monogenic disorders, and the formation of our sister company, ASC Therapeutics (ASCTx) under the Applied StemCell, Inc corporate umbrella. Under the leadership of Dr. Ruby Chen-Tsai who spearheaded the former therapeutics program, Applied..

Also known as: Applied Stemcell, Inc.

Primary location: Milpitas United States